Carregant...
THALIDOMIDE TREATMENT PREVENTS CHRONIC GRAFT REJECTION AFTER AORTIC TRANSPLANTATION IN RATS
BACKGROUND: Cardiac allograft vasculopathy (CAV) affects approximately 30% of cardiac transplant patients at five years post-transplantation. To date there are few CAV treatment or prevention options, none of which are highly effective. The aim of the study was to investigate the effect of thalidomi...
Guardat en:
| Publicat a: | Transpl Int |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5643223/ https://ncbi.nlm.nih.gov/pubmed/28672061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.13004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|